Approach: Developing a highly-sensitive glucose-responsive insulin
Strategic Area: Improving Lives
T1D Funding Impact: Accelerating the development of a novel insulin formulation
Strategic Area: Improving Lives
T1D Funding Impact: Accelerating the development of a novel insulin formulation
Employees: 11-50
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | T1D Fund | t1dfund.or... |
Mentions in press and media 6
| Date | Title | Description |
| 14.07.2021 | Big Pharma Companies Acquire Two SoCal Biotech Startups | Two Southern California biotech startups got swallowed up this week as big pharma benefitted from the record-breaking year of investment in the industry. Pharmaceutical giant Eli Lilly plucked up a Pasadena startup Protomer Technologies for... |
| 14.07.2021 | Eli Lilly gets glucose-sensing “smart insulin” via buyout of preclinical Protomer | Eli Lilly, already a leader in diabetes products, is building on its franchise with the acquisition of Protomer Technologies, a company developing next-generation diabetes drugs capable of sensing blood sugar levels and adjusting accordingl... |
| 09.11.2020 | Pasadena Biopharma Startup Protomer Gets an Investment Boost | Protomer Technologies Inc., a Pasadena-based biopharmaceutical startup, closed a second round of funding to expand the tech platform it's using to develop insulin that adjusts according to a diabetes patient's blood sugar levels. The undisc... |
| 09.11.2020 | Protomer Gets Boost to Develop Glucose Responsive Insulin | Protomer Technologies Inc., a Pasadena-based biopharmaceutical startup, closed a second round of funding to expand the tech platform it's using to develop insulin that adjusts according to a diabetes patient's blood sugar levels. The undisc... |
| 05.11.2020 | Protomer Technologies Gets Funding For Protein Therapeutics | Pasadena-based Protomer Technologies announced this morning that it has received funding from both the JDRF T1D Fund, as well as Eli Lilly and Company, in a funding round. Size of the investment was not announced. The company said Eli Lilly... |
| - | Eli Lilly gets glucose-sensing “smart insulin” via buyout of preclinical Protomer | Eli Lilly, already a leader in diabetes products, is building on its franchise with the acquisition of Protomer Technologies, a company developing next-generation diabetes drugs capable of sensing blood sugar levels and adjusting accordingl... |